About us
Our strategy
Our strategy is to acquire promising early-stage drug candidates from academic and commercial institutions around the world, to manage the development of these drugs through preclinical testing and clinical trials, and to bring them to the market.
Development
Antisoma works with a global network of clinicians and specialist suppliers to advance its drugs through clinical trials. This website includes details of our drugs in development.
Commercialisation
Antisoma expects to bring products to market itself or through parterships with pharmaceutical companies.
Back to top